15 Results for "

DOPAC

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "DOPAC" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-15793
CAS No.: 85081-18-1
Purity:  98.56%
Synonyms: (+)-DTBZ; (+)-α-Dihydrotetrabenazine; (+)-α-DHTBZ
Target:  

Monoamine Transporter

Research Areas:  

Neurological Disease

NBI-98782 is a high affinity and selectivity vesicular monoamine transporter 2 (VMAT2) inhibitor with a Ki of 3 nM. NBI-98782 has antipsychotic activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-42849A
CAS No.: 23694-17-9
Synonyms: LIN-1418 hydrochloride
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Sultopride hydrochloride (LIN-1418 hydrochloride) is a selective antagonist of dopamine D2 receptor.
loading...
    loading...
Cat. No.: HY-14201
CAS No.: 103878-84-8
Purity:  99.95%
Synonyms: Ro 19-6327
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Lazabemide (Ro 19-6327) is a selective, reversible inhibitor of monoamine oxidase B (MAO-B) (IC50=0.03 μM) but less active for MAO-A (IC50>100 μM). Lazabemide inhibits monoamine uptake at high concentrations, the IC50 values are 86 μM, 123 μM and >500 μM for noradrenalin, serotonin and dopamine uptake, respectively. Lazabemide can be used for the research of parkinson and alzheimer′s disease .
loading...
    loading...
Cat. No.: HY-125339
CAS No.: 125628-97-9
Purity:  98.0%
Target:  

COMT Apoptosis

Research Areas:  

Neurological Disease Cancer

Ro 41-0960 is a CNS-penetrant, orally active catechol-O-methyl transferase (COMT) inhibitor. Ro 41-0960 reduces dopamine catabolism, increases striatal dopamine and DOPAC levels, decreases striatal HVA levels, induces apoptosis, inhibits proliferation and extracellular matrix formation in uterine fibroid cells. Ro 41-0960 arrests or shrinks uterine fibroid lesions in rats. Ro 41-0960 can be used for the research of Parkinson’s disease, uterine leiomyomas, and breast cancer .
loading...
    loading...
Cat. No.: HY-106865
CAS No.: 125472-02-8
Mivazerol is a selective α2-adrenoceptor agonist. Mivazerol decreases the spontaneous release of serotonin (5-HT) and significantly inhibits the immobilization stress-induced enhancement of norepinephrine (NE), dopamine (DA) and dihydroxyphenylacetic acid (DOPAC). Mivazerol inhibits intrathecal release of glutamate evoked by halothane withdrawal in rats, and exerts neuroprotective effects in forebrain ischemia rats. Mivazerol can be used for myocardial ischemia research .
loading...
    loading...
Cat. No.: HY-42849
CAS No.: 53583-79-2
Synonyms: LIN-1418
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Sultopride (LIN-1418) is a selective antagonist of dopamine D2 receptor.
loading...
    loading...
Cat. No.: HY-14202
CAS No.: 103878-83-7
Synonyms: Ro 19-6327 hydrochloride
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Lazabemide hydrochloride (Ro 19-6327 hydrochloride) is a selective, reversible inhibitor of monoamine oxidase B (MAO-B) (IC50=0.03 μM) but less active for MAO-A (IC50>100 μM). Lazabemide  inhibits monoamine uptake at high concentrations, the IC50 values are 86 μM, 123 μM and >500 μM for noradrenalin, serotonin and dopamine uptake, respectively. Lazabemide can be used for the research of parkinson and alzheimer′s disease .
loading...
    loading...
Cat. No.: HY-106605
CAS No.: 61325-80-2
Synonyms: LY 120363
Research Areas:  

Neurological Disease

Flumezapine (LY 120363) is a potent and balanced antagonist of the dopamine D2 receptor and the 5-hydroxytryptamine receptor (5-HT receptor). Flumezapine does not alter the increase in serum cortisol caused by κ-opioid receptor agonists. Flumezapine inhibits the conditioned avoidance response in rats and has a low risk of extrapyramidal side effects. Flumezapine can be used in antipsychotic research .
loading...
    loading...
Cat. No.: HY-19061
CAS No.: 111757-17-6
Target:  

COMT

Research Areas:  

Neurological Disease

CGP 28014 is a catechol-O-methyltransferase inhibitor. CGP 28014 can lower HVA levels and increase DOPAC levels in the striatum of rats, making it useful for research on Parkinson's disease .
loading...
    loading...
Cat. No.: HY-19845A
CAS No.: 871351-61-0
Synonyms: ACR-325 hydrochloride
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

Ordopidine hydrochloride is a modulator of dopamine receptor extracted from patent WO/2005/121087A1, compound example 2; exhibits an ED50 of 68 μmol/kg on increase of DOPAC in the rat striatum.
loading...
    loading...
Cat. No.: HY-42849AR
CAS No.: 23694-17-9
Synonyms: LIN-1418 hydrochloride (Standard)
Sultopride hydrochloride (Standard) is the analytical standard of Sultopride hydrochloride. This product is intended for research and analytical applications. Sultopride hydrochloride (LIN-1418 hydrochloride) is a selective antagonist of dopamine D2 receptor.
loading...
    loading...
Cat. No.: HY-W683866
CAS No.: 16378-21-5
Research Areas:  

Neurological Disease

Piroheptine is a muscarinic acetylcholine receptor (mAChR) antagonist and dopamine reuptake inhibitor. Piroheptine blocks the high-affinity dopamine transport system, prevents MPP + uptake into dopaminergic neurons, and exerts anticholinergic activity. Piroheptine completely prevents MPTP (HY-W114750)-induced loss of striatal dopamine and DOPAC, and increases striatal dopamine levels. Piroheptine can be used in studies related to Parkinson's disease .
loading...
    loading...
Cat. No.: HY-P11504
CAS No.: 3109821-26-0
Research Areas:  

Others

Fmoc-Lys-Gly-Dopa-OH is a tripeptide. Fmoc-Lys-Gly-Dopa-OH forms coacervates in aqueous solution via phase separation. Fmoc-Lys-Gly-Dopa-OH coacervates, with the assistance of Fe 3+, provide a viable material to engineer the surface of mammalian cells .
loading...
    loading...
Cat. No.: HY-135242
CAS No.: 72877-72-6
Target:  

Adrenergic Receptor

Research Areas:  

Endocrinology

LY87130 free base is an octopamine-N-methyltransferase inhibitor with epinephrine-inhibiting activity. LY87130 free base can significantly reduce the basal level of epinephrine in the hypothalamus after administration. LY87130 free base has no significant effect on the basal levels of norepinephrine, 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) in the hypothalamus .
loading...
    loading...
Cat. No.: HY-182677
CAS No.: 221452-76-2
Research Areas:  

Neurological Disease

EF-7412 is a dual antagonist of the 5-HT1A receptor and dopamine D2 receptor, with Ki values of 27 nM and 22 nM, respectively. EF-7412 acts as an antagonist at both pre- and postsynaptic 5-HT1A receptor sites, blocking 8-OH-DPAT (HY-112061)-induced hypothermia, behavioral syndrome, and corticosterone elevation in vivo. EF-7412 increases hypothalamic 5-HIAA/5-HT and DOPAC/DA ratios, alters 5-HT and DA neuronal activity, and slightly decreases spontaneous motor activity. EF-7412 can be used for research on 5-HT1A/D2 receptor regulation and related neural pathways .
loading...
    loading...
  • 1